5 Trademark Results found for "SY*RX"

Also try searching for:

SYRX*

*YRX

Details	Status	Class/Description
SYNCORRX Astellas Pharma Inc. 2179738 14 Apr 2022	ADVERTISED on 2 Apr 2025	Computer application software for use with web-based platforms, namely... Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Computer application software for use with web-based platforms, namely, web-based computer applications, and mobile devices, namely, in the nature of tablet computers, personal digital assistants [PDAs], and mobile phones, namely, software for use in accessing a patient's implanted medical device data, namely, implantable wireless microsensors for use in the field of medicine, and transmitting information, namely, in the nature of the diagnosis of disease including the self-management of symptoms and disabilities, the real-time monitoring of physical and biological indicators, namely, heart rate, blood pressure, and body mass index, the management of complex medication regimens in order to maintain proper levels of nutrition, diet or exercise which embodies a patient-centric approach for early disease detection whilst aiding and fostering a closer interaction between patients and healthcare providers.
SYNTHORX SYNTHORX INC. 2066757 10 Jul 2020	REGISTERED on 20 Sept 2023	Protein therapeutics expressed, prepared or manufactured using a semi-... Class 005 Class 005 Pharmaceutical Products Protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunology, namely, for the treatment of immunological disorders, oncology including immuno-oncology, for the treatment of cardiovascular and metabolic diseases, and for the treatment of infectious diseases, namely, respiratory infections; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunology, namely, for the treatment of immunological disorders, rheumatology, namely, for the treatment of rheumatism, oncology including immuno-oncology, pulmonology, namely, for the treatment of respiratory diseases and disorders, gastroenterology, endocrinology, namely, for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, dermatology, namely, for the treatment of dermatitis, eczema, psoriasis, urology, namely, for the treatment of urological diseases, gynecology, namely, for the treatment of gynecological conditions, including fertility, infectiology, including virology namely, for the treatment of viral infections, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), ophthalmology, hepatology namely, for the treatment of hepatological diseases and disorders, neurology, namely, for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and geriatrics, namely, for the treatment of geriatric diseases, namely, arthritis, osteoporosis, hypertension; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors; modified protein to be used in connection with a variety of therapeutic areas, namely protein arrays for medical diagnostic purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology, namely, for the treatment of immunological disorders, rheumatology, namely, for the treatment of rheumatism, oncology including immuno-oncology, pulmonology, namely, for the treatment of respiratory diseases and disorders, gastroenterology, endocrinology, namely, for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, dermatology, namely, for the treatment of dermatitis, eczema, psoriasis, urology, namely, for the treatment of urological diseases, gynecology, namely, for the treatment of gynecological conditions, including fertility, infectiology, including virology namely, for the treatment of viral infections, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), ophthalmology, hepatology namely, for the treatment of hepatological diseases and disorders, neurology, namely, for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and geriatrics, namely, for the treatment of geriatric diseases, namely, arthritis, osteoporosis, hypertension Class 042 Class 042 Computer & Software Services & Scientific Services Medical research; scientific research in the field of DNA; pharmaceutical research and development; laboratory research services in the field of pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, genetics and phenomics, pathology and forensics, proteomics and veterinary medicine and diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents
SYNTHORX SYNTHORX INC. 1945232 8 Feb 2019	REGISTERED on 9 Aug 2024	Protein therapeutics expressed, prepared or manufactured using a semi-... Class 005 Class 005 Pharmaceutical Products Protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunologic diseases and disorders namely, autoimmune diseases and disorders, oncology including immuno-oncology, cardiovascular diseases, and metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, and infectious diseases, namely, urinary tract infections; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunologic diseases and disorders namely, autoimmune diseases and disorders, including rheumatism, oncology including immuno-oncology, pulmonology, namely, respiratory diseases, gastroenterology, endocrine diseases, namely, glucagonoma, dermatological conditions being acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, urology, gynecology, namely, disorders relating to sexual reproduction and fertility, infectiology, namely, anti-viral agents, ophthalmology, hepatological diseases and disorders, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, and geriatric diseases, namely, arthritis, osteoporosis, Dementia, Alzheimer's Disease, and Parkinson's Disease; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunologic diseases and disorders namely, autoimmune diseases and disorders, including rheumatism, oncology including immuno-oncology, pulmonology, namely, respiratory diseases, gastroenterology, endocrine diseases, namely, glucagonoma, dermatological conditions being acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, urology, gynecology, namely, disorders relating to sexual reproduction and fertility, infectiology, namely, anti-viral agents, ophthalmology, hepatological diseases and disorders, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, and geriatric diseases, namely, arthritis, osteoporosis, Dementia, Alzheimer's Disease, and Parkinson's Disease. Class 042 Class 042 Computer & Software Services & Scientific Services Medical research; scientific research in the field of DNA; pharmaceutical research and development; laboratory research services in the field of pharmaceuticals; pharmaceutical research in the field of protein therapeutics; pharmaceutical research in the fields of immunology including rheumatology, oncology including immuno-oncology, pulmonology, gastroenterology, endocrinology, dermatology, urology, gynecology including fertility, infectiology including virology, ophthalmology, hepatology, neurology, geriatrics, genetics and phenomics, pathology and forensics, proteomics, and veterinary medicine and diagnostics; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research using a semi-synthetic organism for use in drug development; pharmaceutical research, namely, research relating to synthetic proteins incorporating one or more non-natural amino acids for improving pharmacological properties; pharmaceutical research, namely, research relating to synthetic proteins for use in connection with a wide variety of therapeutic agents.
SYNDEVRX SYNDEVRX INC. 1857954 18 Sept 2017	REGISTERED on 20 Feb 2020	Pharmaceutical preparations for the treatment of cancer and metabolic ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of cancer and metabolic disorders, namely hyperinsulinemia, hyperglycemia, hyperleptinemia, hypoadiponectinemia, type 2 diabetes, obesity, metabolic syndrome, pre-diabetes and rheumatoid arthritis.
SYMTRX ANUVIA PLANT NUTRIENTS HOLDINGS INC. 1856801 11 Sept 2017	REGISTERED on 5 Aug 2020	Fertilizers for agriculture use. Class 001 Class 001 Chemical Products Fertilizers for agriculture use.

ADVERTISED

on 2 Apr 2025

SYNCORRX

Astellas Pharma Inc.

2179738 · 14 Apr 2022

009

Computer application software for use with web-based platforms, namely...

REGISTERED

on 20 Sept 2023

SYNTHORX

SYNTHORX INC.

2066757 · 10 Jul 2020

005

Class 005

Pharmaceutical Products

Protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunology, namely, for the treatment of immunological disorders, oncology including immuno-oncology, for the treatment of cardiovascular and metabolic diseases, and for the treatment of infectious diseases, namely, respiratory infections; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunology, namely, for the treatment of immunological disorders, rheumatology, namely, for the treatment of rheumatism, oncology including immuno-oncology, pulmonology, namely, for the treatment of respiratory diseases and disorders, gastroenterology, endocrinology, namely, for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, dermatology, namely, for the treatment of dermatitis, eczema, psoriasis, urology, namely, for the treatment of urological diseases, gynecology, namely, for the treatment of gynecological conditions, including fertility, infectiology, including virology namely, for the treatment of viral infections, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), ophthalmology, hepatology namely, for the treatment of hepatological diseases and disorders, neurology, namely, for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and geriatrics, namely, for the treatment of geriatric diseases, namely, arthritis, osteoporosis, hypertension; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors; modified protein to be used in connection with a variety of therapeutic areas, namely protein arrays for medical diagnostic purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunology, namely, for the treatment of immunological disorders, rheumatology, namely, for the treatment of rheumatism, oncology including immuno-oncology, pulmonology, namely, for the treatment of respiratory diseases and disorders, gastroenterology, endocrinology, namely, for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders, dermatology, namely, for the treatment of dermatitis, eczema, psoriasis, urology, namely, for the treatment of urological diseases, gynecology, namely, for the treatment of gynecological conditions, including fertility, infectiology, including virology namely, for the treatment of viral infections, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS), ophthalmology, hepatology namely, for the treatment of hepatological diseases and disorders, neurology, namely, for the treatment of neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and geriatrics, namely, for the treatment of geriatric diseases, namely, arthritis, osteoporosis, hypertension

042

Protein therapeutics expressed, prepared or manufactured using a semi-...

REGISTERED

on 9 Aug 2024

SYNTHORX

SYNTHORX INC.

1945232 · 8 Feb 2019

005

Class 005

Pharmaceutical Products

Protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, pharmaceutical preparations for use in immunologic diseases and disorders namely, autoimmune diseases and disorders, oncology including immuno-oncology, cardiovascular diseases, and metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, and infectious diseases, namely, urinary tract infections; protein therapeutics expressed, prepared or manufactured using a semi-synthetic organism, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer, autoimmune and inflammatory diseases including transplantation and delayed-type hypersensitivity, respiratory diseases, gastrointestinal diseases, cardiovascular and metabolic diseases, pathogen infections, musculoskeletal diseases, ophthalmologic and dermatologic diseases, genitourinary diseases, degenerative diseases, and orphan diseases; protein therapeutics namely, pharmaceutical preparations for use in immunologic diseases and disorders namely, autoimmune diseases and disorders, including rheumatism, oncology including immuno-oncology, pulmonology, namely, respiratory diseases, gastroenterology, endocrine diseases, namely, glucagonoma, dermatological conditions being acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, urology, gynecology, namely, disorders relating to sexual reproduction and fertility, infectiology, namely, anti-viral agents, ophthalmology, hepatological diseases and disorders, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, and geriatric diseases, namely, arthritis, osteoporosis, Dementia, Alzheimer's Disease, and Parkinson's Disease; protein therapeutics, namely, proteins designed to deliver highly targeted therapeutic modulation for patients suffering from a variety of diseases, including cancer and autoimmune disorders, cytokines, interferons, tumor cell targeting and cytolytic agents, tolerogenic and antiallergic factors, growth and differentiation factors, hormones, replacement enzymes, coagulation factors, lipid binding proteins, protein factors for manufacturing of adoptive cell therapy products, anti-infectives, pain killers, and tissue repair factors; non-natural protein modifications for use in connection with a variety of therapeutic areas, namely, protein arrays for medical diagnosis purposes; pharmaceutical preparations, namely, synthetic proteins for use in immunologic diseases and disorders namely, autoimmune diseases and disorders, including rheumatism, oncology including immuno-oncology, pulmonology, namely, respiratory diseases, gastroenterology, endocrine diseases, namely, glucagonoma, dermatological conditions being acne, rosacea, ichthyosis, vitiligo, urticaria and alopecia areata, urology, gynecology, namely, disorders relating to sexual reproduction and fertility, infectiology, namely, anti-viral agents, ophthalmology, hepatological diseases and disorders, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, and geriatric diseases, namely, arthritis, osteoporosis, Dementia, Alzheimer's Disease, and Parkinson's Disease.

042

Protein therapeutics expressed, prepared or manufactured using a semi-...

REGISTERED

on 20 Feb 2020

SYNDEVRX

SYNDEVRX INC.

1857954 · 18 Sept 2017

005

Pharmaceutical preparations for the treatment of cancer and metabolic ...

REGISTERED

on 5 Aug 2020

SYMTRX

ANUVIA PLANT NUTRIENTS HOLDINGS INC.

1856801 · 11 Sept 2017

001

Fertilizers for agriculture use.

Owners

Synthorx inc. (2)

Anuvia plant nutrients holdings inc. (1)

Astellas pharma inc. (1)

Syndevrx inc. (1)

Categories

Class 5 (3)

Class 42 (2)

Class 1 (1)

Class 9 (1)

Correspondents

Smart & biggar lp (2)

Baker & mckenzie llp (1)

Cpst intellectual property inc. (1)

Mcmillan llp (1)

Display

List View

Grid View

Apply for Trademark

Select countries to protect your logo Trademark

Trademark Name

Country Selected

Canada

C$500/ 1 class + gov fee

United States

C$137/ 1 class + gov fee

Canada

C$500/ 1 class + gov fee

Mexico

C$691/ 1 class + gov fee

European Union

C$969/ 1 class + gov fee

China

C$691/ 1 class + gov fee

South Korea

C$967/ 1 class + gov fee

Japan

C$1,106/ 1 class + gov fee

India

C$137/ 1 class + gov fee

United Kingdom

C$691/ 1 class + gov fee

Australia

C$414/ 1 class + gov fee

Israel

C$967/ 1 class + gov fee

United Arab Emirates

C$967/ 1 class + gov fee

New Zealand

C$967/ 1 class + gov fee

Brazil

C$691/ 1 class + gov fee

Taiwan

C$1,106/ 1 class + gov fee

Ukraine

C$1,106/ 1 class + gov fee

Indonesia

C$967/ 1 class + gov fee

South Africa

C$691/ 1 class + gov fee

Singapore

C$1,106/ 1 class + gov fee

Saudi Arabia

C$1,106/ 1 class + gov fee

Afghanistan

C$1,106/ 1 class + gov fee

Algeria

C$1,106/ 1 class + gov fee

Argentina

C$552/ 1 class + gov fee

Austria

C$1,244/ 1 class + gov fee

Bahrain

C$967/ 1 class + gov fee

Bangladesh

C$829/ 1 class + gov fee

Benelux

C$1,382/ 1 class + gov fee

Bhutan

C$1,244/ 1 class + gov fee

Bolivia

C$1,106/ 1 class + gov fee

Botswana

C$1,797/ 1 class + gov fee

British Virgin Islands

C$1,659/ 1 class + gov fee

Bulgaria

C$1,106/ 1 class + gov fee

Cambodia

C$1,106/ 1 class + gov fee

Chile

C$691/ 1 class + gov fee

Colombia

C$967/ 1 class + gov fee

Congo

C$1,659/ 1 class + gov fee

Costa Rica

C$1,244/ 1 class + gov fee

Croatia

C$1,244/ 1 class + gov fee

Cyprus

C$1,382/ 1 class + gov fee

Czech Republic

C$1,244/ 1 class + gov fee

Denmark

C$1,106/ 1 class + gov fee

Curacao

C$1,659/ 1 class + gov fee

Macau

C$967/ 1 class + gov fee

Dominican Republic

C$1,244/ 1 class + gov fee

Aruba

C$1,659/ 1 class + gov fee

Greenland

C$1,106/ 1 class + gov fee

Ecuador

C$1,106/ 1 class + gov fee

Egypt

C$967/ 1 class + gov fee

El Salvador

C$1,106/ 1 class + gov fee

Ethiopia

C$1,521/ 1 class + gov fee

France

C$1,244/ 1 class + gov fee

Gaza

C$1,106/ 1 class + gov fee

Germany

C$1,244/ 1 class + gov fee

Greece

C$1,106/ 1 class + gov fee

Guatemala

C$1,244/ 1 class + gov fee

Haiti

C$1,244/ 1 class + gov fee

Honduras

C$1,244/ 1 class + gov fee

Hong Kong (SAR)

C$1,244/ 1 class + gov fee

Hungary

C$1,521/ 1 class + gov fee

Iraq

C$2,074/ 1 class + gov fee

Italy

C$1,244/ 1 class + gov fee

Jordan

C$1,106/ 1 class + gov fee

Kazakhstan

C$1,106/ 1 class + gov fee

Kenya

C$1,244/ 1 class + gov fee

Kuwait

C$1,106/ 1 class + gov fee

Laos

C$967/ 1 class + gov fee

Lebanon

C$1,382/ 1 class + gov fee

Lesotho

C$1,659/ 1 class + gov fee

Libya

C$1,244/ 1 class + gov fee

Madrid Protocol (WIPO)

C$2,766/ 1 class + gov fee

Malawi

C$1,521/ 1 class + gov fee

Malaysia

C$967/ 1 class + gov fee

Maldives

C$1,382/ 1 class + gov fee

Morocco

C$1,382/ 1 class + gov fee

Mozambique

C$1,244/ 1 class + gov fee

Myanmar

C$1,106/ 1 class + gov fee

Namibia

C$1,106/ 1 class + gov fee

Nepal

C$967/ 1 class + gov fee

Nicaragua

C$1,244/ 1 class + gov fee

Norway

C$1,244/ 1 class + gov fee

Oman

C$1,521/ 1 class + gov fee

Pakistan

C$1,106/ 1 class + gov fee

Panama

C$1,244/ 1 class + gov fee

Paraguay

C$1,244/ 1 class + gov fee

Peru

C$1,106/ 1 class + gov fee

Philippines

C$1,244/ 1 class + gov fee

Poland

C$691/ 1 class + gov fee

Portugal

C$1,244/ 1 class + gov fee

Puerto Rico

C$1,244/ 1 class + gov fee

Qatar

C$1,106/ 1 class + gov fee

Romania

C$1,244/ 1 class + gov fee

Serbia

C$1,244/ 1 class + gov fee

Slovakia

C$1,244/ 1 class + gov fee

Spain

C$1,244/ 1 class + gov fee

Sri Lanka

C$967/ 1 class + gov fee

Swaziland

C$1,797/ 1 class + gov fee

Sweden

C$1,106/ 1 class + gov fee

Switzerland

C$1,244/ 1 class + gov fee

Thailand

C$1,106/ 1 class + gov fee

Tunisia

C$1,244/ 1 class + gov fee

Turkey

C$1,106/ 1 class + gov fee

Uganda

C$967/ 1 class + gov fee

United Republic of Tanzania

C$967/ 1 class + gov fee

Uruguay

C$1,106/ 1 class + gov fee

Venezuela

C$1,244/ 1 class + gov fee

Vietnam

C$1,106/ 1 class + gov fee

West Bank, Palestine

C$1,106/ 1 class + gov fee

Yemen

C$2,351/ 1 class + gov fee

Albania

C$1,244/ 1 class + gov fee

Andorra

C$1,244/ 1 class + gov fee

Angola

C$1,797/ 1 class + gov fee

Antigua and Barbuda

C$1,659/ 1 class + gov fee

Armenia

C$1,106/ 1 class + gov fee

Azerbaijan

C$1,106/ 1 class + gov fee

Bahamas

C$1,936/ 1 class + gov fee

Barbados

C$1,797/ 1 class + gov fee

Belgium

C$1,382/ 1 class + gov fee

Belize

C$1,797/ 1 class + gov fee

Benin

C$1,106/ 1 class + gov fee

Bosnia and Herzegovina

C$1,382/ 1 class + gov fee

Brunei

C$1,797/ 1 class + gov fee

Burkina Faso

C$1,106/ 1 class + gov fee

Burundi

C$1,659/ 1 class + gov fee

Cabo Verde

C$1,244/ 1 class + gov fee

Cameroon

C$1,106/ 1 class + gov fee

Central African Republic (CAR)

C$1,106/ 1 class + gov fee

Chad

C$1,106/ 1 class + gov fee

Comoros

C$1,106/ 1 class + gov fee

Cote d'Ivoire

C$1,106/ 1 class + gov fee

Czechia

C$1,382/ 1 class + gov fee

Djibouti

C$1,659/ 1 class + gov fee

Dominica

C$1,797/ 1 class + gov fee

Equatorial Guinea

C$1,106/ 1 class + gov fee

Eritrea

C$1,382/ 1 class + gov fee

Estonia

C$1,797/ 1 class + gov fee

Eswatini

C$1,797/ 1 class + gov fee

Fiji

C$1,244/ 1 class + gov fee

Finland

C$967/ 1 class + gov fee

Gabon

C$1,106/ 1 class + gov fee

Gambia

C$1,244/ 1 class + gov fee

Georgia

C$1,106/ 1 class + gov fee

Ghana

C$1,382/ 1 class + gov fee

Grenada

C$1,797/ 1 class + gov fee

Guinea

C$1,106/ 1 class + gov fee

Guinea-Bissau

C$1,106/ 1 class + gov fee

Guyana

C$1,797/ 1 class + gov fee

Iceland

C$1,797/ 1 class + gov fee

Ireland

C$1,244/ 1 class + gov fee

Jamaica

C$1,659/ 1 class + gov fee

Kiribati

C$1,382/ 1 class + gov fee

Kosovo

C$1,244/ 1 class + gov fee

Kyrgyzstan

C$1,244/ 1 class + gov fee

Latvia

C$967/ 1 class + gov fee

Liberia

C$1,382/ 1 class + gov fee

Liechtenstein

C$1,382/ 1 class + gov fee

Lithuania

C$967/ 1 class + gov fee

Luxembourg

C$1,382/ 1 class + gov fee

Madagascar

C$1,382/ 1 class + gov fee

Mali

C$1,106/ 1 class + gov fee

Malta

C$829/ 1 class + gov fee

Marshall Islands

C$1,382/ 1 class + gov fee

Mauritania

C$1,106/ 1 class + gov fee

Mauritius

C$1,382/ 1 class + gov fee

Micronesia

C$1,382/ 1 class + gov fee

Moldova

C$1,382/ 1 class + gov fee

Monaco

C$1,936/ 1 class + gov fee

Mongolia

C$829/ 1 class + gov fee

Montenegro

C$1,244/ 1 class + gov fee

Nauru

C$1,382/ 1 class + gov fee

Netherlands

C$1,382/ 1 class + gov fee

Niger

C$1,106/ 1 class + gov fee

Nigeria

C$552/ 1 class + gov fee

North Macedonia

C$1,244/ 1 class + gov fee

Palau

C$1,382/ 1 class + gov fee

Palestine

C$1,382/ 1 class + gov fee

Papua New Guinea

C$1,106/ 1 class + gov fee

Rwanda

C$1,382/ 1 class + gov fee

Saint Kitts and Nevis

C$1,797/ 1 class + gov fee

Saint Lucia

C$1,797/ 1 class + gov fee

Saint Vincent and the Grenadines

C$1,797/ 1 class + gov fee

Samoa

C$1,659/ 1 class + gov fee

San Marino

C$1,382/ 1 class + gov fee

Sao Tome and Principe

C$1,382/ 1 class + gov fee

Senegal

C$1,106/ 1 class + gov fee

Seychelles

C$1,382/ 1 class + gov fee

Sierra Leone

C$1,382/ 1 class + gov fee

Slovenia

C$1,244/ 1 class + gov fee

Solomon Islands

C$1,382/ 1 class + gov fee

Somalia

C$1,382/ 1 class + gov fee

South Sudan

C$1,382/ 1 class + gov fee

Suriname

C$2,212/ 1 class + gov fee

Tajikistan

C$1,106/ 1 class + gov fee

Tanzania

C$967/ 1 class + gov fee

Timor-Leste

C$1,382/ 1 class + gov fee

Togo

C$1,106/ 1 class + gov fee

Tonga

C$1,797/ 1 class + gov fee

Trinidad and Tobago

C$1,659/ 1 class + gov fee

Turkmenistan

C$1,106/ 1 class + gov fee

Tuvalu

C$1,382/ 1 class + gov fee

Uzbekistan

C$967/ 1 class + gov fee

Vanuatu

C$1,659/ 1 class + gov fee

Zambia

C$1,244/ 1 class + gov fee

Zimbabwe

C$1,244/ 1 class + gov fee

OAPI

C$1,244/ 1 class + gov fee

ARIPO

C$1,382/ 1 class + gov fee

End of search results

Page 1 of 1